Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
JAPAN: +81-50-5539-1737
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Hepatitis B is an infection which is caused due to transmission of the virus through contact with the body fluids such as blood of an infected person. This condition affects the liver, leads to acute and chronic diseases. Chinese hamster ovary cell (CHO) hepatitis B vaccine is used to prevent hepatitis B infection. The vaccine can be classified into Pediatric Hepatitis B (CHO) Vaccine and Adult Hepatitis B (CHO) Vaccine.

The growing prevalence of increase in the prevalence of hepatitis B infection around the globe is a prime factor fueling the market growth. Increasing penetration of vaccines for treating hepatitis B infection is expected to supplement the market growth. According to the World Health Organization, in 2019, coverage of 3 doses of the vaccine reached 85% worldwide compared to around 30% in 2000. However, coverage of the hepatitis B vaccine birth dose remains uneven. Moreover, increasing government initiatives to promote (CHO) hepatitis B vaccination for adults coupled with the growing R &D in the field of hepatitis B is further projected to foster the market growth of the recombinant Chinese hamster ovary cell (CHO) Hepatitis B Vaccine.

From the geographical point of view, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of hepatitis B infection in the region. According to the National Center for Health Statistics, during 2015–2018, in the United States, the prevalence of any past or present HBV infection was 4.3% among adults aged 18 and over. Prevalence was higher among men (5.3%) compared with women (3.4%). Prevalence was highest among non-Hispanic Asian adults (21.1%), followed by non-Hispanic blacks (10.8%), Hispanic (3.8%), and non-Hispanic white (2.1%) adults.

Key Developments:

  1. In July 2020, Dynavax Technologies Corporation, a biopharmaceutical company, and Times Pharmacy have partnered with Hep Free Hawaii to offer HEPLISAV-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] at pharmacy locations on Oahu, with a focus on people living with diabetes.
  2. In August 2020, GSK announced that GSK’836 (GSK3228836), an investigational antisense oligonucleotide, showed marked reductions in hepatitis B surface antigen (HBsAg) and hepatitis B virus DNA compared with placebo after four weeks of treatment in people with chronic hepatitis B on stable nucleoside or nucleotide analogue (NA) therapy and in patients who were NA-naïve.
  3. In February 2017, Drug firm Cipla in collaboration with Serum Institute of India (SII) launched the Hepatitis B vaccine for adults.

The Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Merck & Co., Inc.
  • GlaxoSmithKline Plc
  • Pfizer Inc.
  • Sanofi Pasteur
  • CSL Limited
  • Emergent Biosolutions
  • Serum Institute of India
  • Johnson & Johnson

By the Product Type, the market is primarily segmented into:

  • Pediatric Hepatitis B (CHO) Vaccine
  • Adult Hepatitis B (CHO) Vaccine

By Applications, the market is segmented into:

  • Hospitals
  • Clinics

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market

The Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Recombinant Hamster Ovary Cell Cho Hepatitis B Vaccine Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Overview
1.1 Product Overview and Scope of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Type
1.2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Pediatric Hepatitis B (CHO) Vaccine
1.2.3 Adult Hepatitis B (CHO) Vaccine
1.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Segment by Application
1.3.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market by Region
1.4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size
1.5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (2014-2025)
1.5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (2014-2025)

2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competition by Manufacturers
2.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Manufacturers (2014-2019)
2.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2014-2019)
2.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites, Area Served, Product Types
2.5 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Competitive Situation and Trends
2.5.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Concentration Rate
2.5.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Regions
3.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Regions
3.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Regions (2014-2019)
3.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production
3.4.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
3.4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production
3.5.1 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
3.5.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production
3.6.1 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
3.6.2 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production
3.7.1 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
3.7.2 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption by Regions
4.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption by Regions
4.2 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (2014-2019)
4.3 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (2014-2019)
4.4 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (2014-2019)
4.5 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (2014-2019)

5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price Trend by Type
5.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Type (2014-2019)
5.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Type (2014-2019)
5.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price by Type (2014-2019)
5.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth by Type (2014-2019)

6 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Analysis by Applications
6.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Application (2014-2019)
6.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Business
7.1 Merck & Co., Inc.
7.1.1 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.1.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.1.3 Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.2.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.2.3 GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.3.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.3.3 Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.4.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.4.3 Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 CSL Limited
7.5.1 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.5.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.5.3 CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Emergent Biosolutions
7.6.1 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.6.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.6.3 Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Serum Institute of India
7.7.1 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.7.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.7.3 Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
7.8.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Introduction, Application and Specification
7.8.3 Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served

8 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Manufacturing Cost Analysis
8.1 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
8.4 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List
9.3 Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Forecast
11.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue Forecast
11.1.1 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate Forecast (2019-2025)
11.1.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price and Trend Forecast (2019-2025)
11.2 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Forecast by Regions (2019-2025)
11.2.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue Forecast (2019-2025)
11.2.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue Forecast (2019-2025)
11.2.3 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue Forecast (2019-2025)
11.2.4 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue Forecast (2019-2025)
11.3 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast by Regions (2019-2025)
11.3.1 North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast (2019-2025)
11.3.2 Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast (2019-2025)
11.3.3 China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast (2019-2025)
11.3.4 Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast (2019-2025)
11.4 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures

Figure Picture of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Growth Rate Comparison by Types (2014-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Types in 2018
Figure Pediatric Hepatitis B (CHO) Vaccine Product Picture
Table Pediatric Hepatitis B (CHO) Vaccine Major Manufacturers
Figure Adult Hepatitis B (CHO) Vaccine Product Picture
Table Adult Hepatitis B (CHO) Vaccine Major Manufacturers
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Comparison by Applications (2014-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) (2014-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) (2014-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) of Key Manufacturers (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Share by Manufacturers (2014-2019)
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Share by Manufacturers in 2018
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Manufacturers in 2018
Table Global Market Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (USD/Dose) of Key Manufacturers (2014-2019)
Figure Global Market Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Average Price (USD/Dose) of Key Manufacturers in 2018
Table Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Manufacturers Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Product Types
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share of Top 5 Manufacturers
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Market Share of Top 10 Manufacturers
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) by Region (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Region (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Region (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share by Region in 2018
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) by Region (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share by Region in 2018
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2014-2019)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Growth Rate (2014-2019)
Table North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Growth Rate (2014-2019)
Table China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Growth Rate (2014-2019)
Table Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Market by Region (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Region (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Region (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Region in 2018
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate (2014-2019) (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) by Type (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Share by Type (2014-2019)
Figure Production Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type (2014-2019)
Figure Production Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type in 2018
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) by Type (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Share by Type (2014-2019)
Figure Revenue Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type (2014-2019)
Figure Revenue Market Share of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine by Type in 2018
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) by Type (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth by Type (2014-2019) (K Doses)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) by Application (2014-2019)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Application (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Applications (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share by Application in 2018
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate by Application (2014-2019)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Growth Rate by Application (2014-2019)
Table Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Merck & Co., Inc. Product Introduction, Application and Specification
Table Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure Merck & Co., Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Main Business and Markets Served
Table GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table GlaxoSmithKline Plc Product Introduction, Application and Specification
Table GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure GlaxoSmithKline Plc Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table GlaxoSmithKline Plc Main Business and Markets Served
Table Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Pfizer Inc. Product Introduction, Application and Specification
Table Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure Pfizer Inc. Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table Pfizer Inc. Main Business and Markets Served
Table Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Sanofi Pasteur Product Introduction, Application and Specification
Table Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure Sanofi Pasteur Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table Sanofi Pasteur Main Business and Markets Served
Table CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table CSL Limited Product Introduction, Application and Specification
Table CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure CSL Limited Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table CSL Limited Main Business and Markets Served
Table Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Emergent Biosolutions Product Introduction, Application and Specification
Table Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure Emergent Biosolutions Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table Emergent Biosolutions Main Business and Markets Served
Table Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Serum Institute of India Product Introduction, Application and Specification
Table Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure Serum Institute of India Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table Serum Institute of India Main Business and Markets Served
Table Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Sites and Area Served
Table Johnson & Johnson Product Introduction, Application and Specification
Table Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Figure Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Growth Rate (2014-2019)
Figure Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share (2014-2019)
Figure Johnson & Johnson Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share (2014-2019)
Table Johnson & Johnson Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
Figure Manufacturing Process Analysis of Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine
Figure Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Industrial Chain Analysis
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Distributors List
Table Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price and Trend Forecast (2019-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Forecast by Region (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production Market Share Forecast by Region (2019-2025)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) and Growth Rate Forecast (2019-2025)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Forecast by Regions (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Europe Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure China Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Figure Japan Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Growth Rate Forecast (2019-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Forecast by Type (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Production (K Doses) Forecast by Type (2019-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Revenue Market Share Forecast by Type (2019-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Price (USD/Dose) Forecast by Type (2019-2025)
Table Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption (K Doses) Forecast by Application (2019-2025)
Figure Global Recombinant Hamster Ovary Cell (CHO) Hepatitis B Vaccine Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us